To hear about similar clinical trials, please enter your email below

Trial Title: Discovering Cancer Risks From Environmental Contaminants and Maternal/Child Health

NCT ID: NCT05746169

Condition: Cancer

Conditions: Keywords:
Cancer Risk
Environmental Cancer Risk
Maternal-Child Cancer Risk
Environmental Contaminants

Study type: Observational

Overall status: Recruiting

Study design:

Time perspective: Prospective

Intervention:

Intervention type: Other
Intervention name: Health Questionnaires
Description: A questionnaire with content developed and tested in the investigator's previous reproductive and cancer epidemiology studies as part of the NIH Environmental Influences on Child Health Outcomes (ECHO) consortium will be used to collect information on primary established and hypothesized risk factors for cancer and additional covariates.
Arm group label: Pregnant women and their children

Intervention type: Other
Intervention name: Specimen sample collection
Description: Collection of blood, urine, nails, hair, and saliva samples will be obtained during the participant encounters.
Arm group label: Pregnant women and their children

Other name: Biospecimen sample collection

Other name: Specimen collection

Summary: The DREAM Cohort is a longitudinal observational study developed to enhance our understanding of how multiple exposures to environmental chemicals and pollutants across a diverse population of pregnant women and their offspring are linked to cancer risks. Because pregnancy induces multiple maternal hormonal and physiological changes that can increase cancer susceptibility to environmental chemical exposures, this study will focus on pregnancy as a period of particular vulnerability to toxic agents.

Detailed description: The environmental exposures will focus on two major components: Consumer product related chemicals (including per- and polyfluoroalkyl substances (PFAS), phthalates and plasticizers, phenolic compounds, pesticides, and aromatic amines) measured via biomonitoring and prioritized based on widespread public exposure; and environmental pollutants in air and water, evaluated via geographic information system analyses of participants' residential histories. The study team will collect questionnaire data and biospecimen samples starting at the second trimester of pregnancy up until the child reaches four years of age. A Cohort Ambassador Program will also be established to invite participants across our three sites to provide continuous feedback which will be integrated into the research priorities.

Criteria for eligibility:

Study pop:
Pregnant women and their children

Sampling method: Non-Probability Sample
Criteria:
Inclusion Criteria: - Pregnant women, over the age of 18 years. - English or Spanish-speaking. - Children born of participants enrolled during pregnancy will be enrolled in the DREAM cohort. - Inclusion criterion for the DREAM Cohort Ambassador Program is limited to research participants in the DREAM Cohort. Exclusion Criteria: - Women under the age of 18. - Women expecting the birth of multiples (twins, triplets, etc.).

Gender: All

Minimum age: 18 Years

Maximum age: N/A

Healthy volunteers: Accepts Healthy Volunteers

Locations:

Facility:
Name: University of California, Berkeley

Address:
City: Berkeley
Zip: 94720
Country: United States

Status: Recruiting

Investigator:
Last name: Rachel Morello-Frosch, PhD
Email: Principal Investigator

Facility:
Name: Fresno Community Regional Medical Center

Address:
City: Fresno
Zip: 93721
Country: United States

Status: Recruiting

Investigator:
Last name: Amy (Meg) Autry, MD
Email: Principal Investigator

Facility:
Name: University of California, San Francisco

Address:
City: San Francisco
Zip: 94143
Country: United States

Status: Recruiting

Contact:
Last name: Erin DeMicco

Phone: 415-476-3220
Email: Erin.DeMicco@ucsf.edu

Investigator:
Last name: Peggy Reynolds, PhD
Email: Principal Investigator

Investigator:
Last name: Tracey Woodruff, PhD, MPH
Email: Sub-Investigator

Start date: September 1, 2021

Completion date: August 31, 2027

Lead sponsor:
Agency: University of California, San Francisco
Agency class: Other

Collaborator:
Agency: National Cancer Institute (NCI)
Agency class: NIH

Collaborator:
Agency: California Office of Environmental Health Hazard Assessment (OEHHA)
Agency class: Other

Source: University of California, San Francisco

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT05746169

Login to your account

Did you forget your password?